Cambridge Enterprise Ventures is the University of Cambridge’s venture fund in Cambridge, United Kingdom, backing Cambridge spin-outs and start-ups from company formation through seed, early-stage and later-stage follow-on rounds. It invests in research-driven deep tech, life sciences, biotechnology, clean technology, climate, energy, materials, sustainability, oncology and pharmaceuticals, with investment activity across the United Kingdom and Switzerland. The fund can invest over £2 million across multiple rounds and has backed companies including Riverlane and T-Therapeutics.